Search
for
Sort by
Research 691–720 of 1000+
- Efficacy of autologous Platelet-rich plasma therapy versus topical Minoxidil in men with moderate androgenetic alopecia: A randomized open-label trial
- Efficacy of low-level laser therapy in androgenetic alopecia – A randomized controlled trial
- Racial and Ethnic Disparities in Androgenetic Alopecia Clinical Trials in the United States
- 303 The role of rare variants in male-pattern hair loss: Analysis of whole exome sequencing data in the UK Biobank
- Efficacy and safety of combined with microneedling therapy for androgenic alopecia: A systematic review and meta-analysis of randomized clinical trials
- Major randomized clinical studies of alopecia treatment with platelet-rich plasma: a systematic review
- ESDR303 – The role of rare variants in male-pattern hair loss: Analysis of whole exome sequencing data in the UK Biobank
- Radiofrequency Current at 448 Khz For Female Pattern Hair Loss: Cellular Bases For Redensification Improvement
- Faculty Opinions recommendation of Sublingual minoxidil for the treatment of male and female pattern hair loss: a randomized, double-blind, placebo-controlled, phase 1B clinical trial.
- Randomized control trial to study the efficacy and safety of platelet-rich plasma as intraoperative holding solution in hair restoration surgery: A pilot study
- Nonablative radiofrequency for the treatment of androgenetic alopecia: An open‐label study
- Effectiveness of Topical Minoxidil (5%) Plus Topical Finasteride (0.1%) Fixed-Dose Combination Versus Topical Minoxidil (5%) Plus Oral Finasteride (1 Mg/Day) in Grade II-IV Androgenetic Alopecia: A Randomized, Double Blind Clinical Trial
- DRUG POLYMORPHISM IDENTIFICATION USING FOURIER TRANSFORM-RAMAN SPECTROSCOPY: A COMPARATIVE STUDY OF LAMIVUDINE AND FINASTERIDE DRUGS
- Raw data from JAAD research letter: Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign”
- Correction to: Comparative Study to Evaluate Tolerability of Topical 5% Minoxidil Novel Formulation and Alcohol-Based Conventional Solutions in Treatment of Androgenetic Alopecia in Indian Men: Randomized Double-Blind Study
- Comparative Study to Evaluate Tolerability of Topical 5% Minoxidil Novel Formulation and Alcohol-Based Conventional Solutions in Treatment of Androgenetic Alopecia in Indian Men: Randomized Double-Blind Study
- Identification and Detection of Finasteride Polymorphs in Finasteride Tablets by FT-Raman Spectroscopy
- Rare case of Leydig cell tumor with type I diabetes mellitus causing female pattern hair loss
- EP-2270: Novel protective effect of prostaglandin for timely hair follicle regeneration from radiation injury
- Faculty Opinions recommendation of Efficacy and Safety of Once-Daily Minoxidil Foam 5% Versus Twice-Daily Minoxidil Solution 2% in Female Pattern Hair Loss: A Phase III, Randomized, Investigator-Blinded Study.
- Faculty Opinions recommendation of Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, double-blind study.
- Experiments in Raman Spectroscopy on Hair Follicles from Females with Androgenetic Alopecia
- A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men
- A Rapid Extraction Procedure of Human Hair Proteins and Identification of Phosphorylated Species.
- A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss
- A randomized, double-blind, placebo- and active-controlled, half-head study to evaluate the effects of platelet-rich plasma on alopecia areata
- Sulforaphane mobilizes cellular defenses that protect skin against damage by UV radiation
- The malignant capacity of skin tumours induced by expression of a mutant H-ras transgene depends on the cell type targeted
- A Phase I Study of Topical Tempol for the Prevention of Alopecia Induced by Whole Brain Radiotherapy
- A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis).